Aptevo Therapeutics Inc. (APVO) Free cash flow 2016–2023
Aptevo Therapeutics Inc. (APVO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$11.8MFY2023 · since FY2016: -$38.4M → -$11.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$11.8M | +45.9% |
| FY2022 | -$21.7M | +0.1% |
| FY2021 | -$21.8M | +26.1% |
| FY2020 | -$29.5M | +32.0% |
| FY2019 | -$43.4M | +17.9% |
| FY2018 | -$52.8M | -19.8% |
| FY2017 | -$44.1M | -14.8% |
| FY2016 | -$38.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice